Roivant chief Vivek Ramaswamy is picking up his $3 billion check from Sumitomo Dainippon in exchange for his stake in 5 of his startup vants — along with an option on 6 more as well as an operations team to oversee their work. And the Japanese pharma is spicing up the deal with a $350 million loan to one of the key players it’s picking up in the transaction today.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,